Imunon (IMNN) Accumulated Expenses (2011 - 2026)

Imunon (IMNN) has 16 years of Accumulated Expenses data on file, last reported at $1.7 million in Q1 2026.

• Quarterly Accumulated Expenses fell 33.89% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 33.89% YoY) and the FY2025 annual result came in at $1.6 million, down 46.87% from the prior year.
• Accumulated Expenses advanced to $1.7 million in Q1 2026, from $1.6 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $4.8 million in Q4 2022 to a low of $1.5 million in Q2 2023.
• A 5-year average of $2.8 million and a median of $2.8 million in 2023 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses jumped 24057.3% — and 2023, when it slumped 61.51%.
• Tracing IMNN's Accumulated Expenses over 5 years: stood at $4.8 million in 2022, then declined by 29.29% to $3.4 million in 2023, then fell by 10.52% to $3.0 million in 2024, then tumbled by 46.87% to $1.6 million in 2025, then increased by 4.61% to $1.7 million in 2026.
• The last three Accumulated Expenses figures came in at $1.7 million (Q1 2026), $1.6 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.